CG Oncology Announces Publication Of Pivotal Phase 3 BOND-003 Cohort C Study Results In The Lancet Oncology
CG Oncology announced the publication of pivotal Phase 3 BOND-003 Cohort C study results in The Lancet Oncology, highlighting key findings for its cancer therapy.
ARGAN : STANDARD & POOR’S EMET UN CREDIT WATCH POSITIF SUR LA NOTATION « BBB- »
Standard & Poor’s places Argan’s ‘BBB-‘ credit rating on positive watch, signaling potential upgrade. Impact on investors and credit outlook explained.
Ascentage Pharma Chairman And CEO Dr. Dajun Yang Named To The Medicine Maker Power List 2026
Ascentage Pharma’s Chairman and CEO Dr. Dajun Yang has been recognized in The Medicine Maker Power List 2026, highlighting his influence in the pharmaceutical industry.
Banco Comercial Português, S.A. Informs About Interim Report On The Transactions Conducted Under The Share Buy- Back Programme
Banco Comercial Português, S.A. has published its interim report detailing transactions under its share buy-back program, providing transparency to investors.